CTXR - Aset Neraca Perusahaan Citius Pharma

This daily price chart for Citius Pharmaceuticals (CTXR) on the GURU.Markets platform reflects total assets at 134.94. Citius Pharmaceuticals is expanding its presence in the hospital sector through the supply of effective catheter solutions. The business remains independent of economic cycles, although it is sensitive to the cost of borrowed capital. Profit growth relies on the launch of Mino-Lok and the potential launch of the antineoplastic Lymphir.

The commercialization of Mino-Lok and oncology drugs directly impacts total assets, reflecting the resource base for scaling developments at Citius Pharmaceuticals (CTXR). This indicator, reverse-calculated via ROA, integrates equity and liabilities into daily price action, allowing investors to track the company's financial stability between reports and timely identify risks of a deep capital drawdown.